| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $38.11M | $56.79M | $69.64M | $42.26M | $21.57M |
| R&D | $24.77M | $40.49M | $54.87M | $28.51M | $16.16M |
| SG&A | $13.34M | $14.07M | $14.76M | $12.75M | $4.67M |
| Operating Income | -$38.11M | -$56.79M | -$69.64M | -$42.26M | -$21.57M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$35.17M | -$51.32M | -$64.73M | -$40.96M | -$21.54M |
| EPS (basic) | -1.1600 | -1.7200 | -2.7400 | -2.7900 | -10.6400 |
| EPS (diluted) | -1.1600 | -1.7200 | -2.7400 | -2.7900 | -10.6400 |
| Shares (diluted) | $30.22M | $29.83M | $23.60M | $15.34M | $2.64M |